Siegel™ TAVR

About MiRus

MiRus is a privately-held medical device innovator founded in 2007, built around its patented MoRe® alloy, which offers superior strength, biocompatibility, and reduced metal ion release compared to traditional materials like titanium. The company has successfully transitioned multiple products to the commercial stage, with a growing pipeline in spine, orthopedics, and transcatheter heart valves, as evidenced by recent FDA clearances and a New Technology Add-on Payment (NTAP). Operating as an integrated platform company, MiRus combines novel biomaterials, implant design, procedural solutions, and remote monitoring to improve patient outcomes across the continuum of care.

Therapeutic Areas